MedTrace Logo

Phase II Study Evaluating Strategies of Lung Surveillance of Patients Operated of High Grade Soft Tissue Sarcoma

NCT01612481 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2026-03-16

No results posted yet for this study

Summary

Cancer surveillance has a significant cost and generate anxiety for the patient.

It is important to avoid exams that will not modify health support or whose results wont allow to decide.

Conditions

  • Soft Tissue Sarcoma
  • Lung Metastasis

Interventions

PROCEDURE

chest radiography

surveillance by radiography of chest every 3 months the first 2 years then every 6 month the third, forth and fifth years

PROCEDURE

chest CT

surveillance by CT of chest every 3 months the first 2 years then every 6 month the third, forth and fifth years

Sponsors & Collaborators

  • Centre Oscar Lambret

    lead OTHER

Principal Investigators

  • Nicolas PENEL, MD · Oscar Lambret Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-02
Primary Completion
2015-10-31
Completion
2016-05-19

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01612481 on ClinicalTrials.gov